Acesso livre
Acesso livre

Saúde Pública/Medicina Humanitária

Estudo compara a queda da efetividade das vacinas da Moderna, da Pfizer e da Janssen, além das consequências para a mortalidade.

5 Nov, 2021 | 17:21h

Estudo original: SARS-CoV-2 vaccine protection and deaths among US veterans during 2021 – Science

Comunicado de imprensa: Breakthrough Infection Study Compares Decline in Vaccine Effectiveness and Consequences for Mortality – Public Health Institute

 

Comentário no Twitter

 

Efeitos da pandemia de Covid-19 na expectativa de vida e na mortalidade prematura em 2020 – Esta análise mostrou que houve mais de 28 milhões de anos a mais de vida perdidos em 2020 em 31 países.

5 Nov, 2021 | 17:20h

Effects of covid-19 pandemic on life expectancy and premature mortality in 2020: time series analysis in 37 countries – The BMJ

Conteúdos relacionados:

Global Covid-19 deaths surpass five million.

Under-reporting of deaths limits our understanding of true burden of covid-19.

Study shows COVID-19 has caused the biggest decrease in life expectancy since World War II.

Just how do deaths due to COVID-19 stack up?

Tracking excess mortality across countries during the COVID-19 pandemic with the World Mortality Dataset.

Exploring the gap between excess mortality and COVID-19 deaths in 67 countries.

Report: Three new estimates of India’s all-cause excess mortality during the COVID-19 Pandemic – pandemic death toll estimated to be between 3.4 million and 4.9 million excess deaths.

COVID-19 has caused 6.9 million deaths globally, more than double what official reports show

 

Comentário do autor no Twitter (fio – clique para saber mais)

 

Revisão | Transmissão do SARS-CoV-2 pelo ar em ambientes fechados é uma ameaça que pode ser combatida com ciência.

5 Nov, 2021 | 17:17h

SARS-CoV-2 indoor air transmission is a threat that can be addressed with science – Proceedings of the National Academies of Sciences

Conteúdos relacionados:

Ten scientific reasons in support of airborne transmission of SARS-CoV-2

Editorial: Covid-19 has redefined airborne transmission

Covid-19: What do we know about airborne transmission of SARS-CoV-2?

Real-world data show that filters clean COVID-causing virus from air.

Perspective | The plan to stop every respiratory virus at once – “The benefits of ventilation reach far beyond the coronavirus. What if we stop taking colds and flus for granted, too?”

Recommendations for ventilation of indoor spaces to reduce COVID-19 transmission.

We studied how to reduce airborne COVID spread in hospitals. Here’s what we learnt.

Report: Improved ventilation essential to safe use of buildings and public spaces, say leading engineers.

WHO: Roadmap to improve and ensure good indoor ventilation in the context of COVID-19

CDC releases new ventilation guidelines for indoor environments to reduce Covid-19 risk

Guidance: Using Ventilation and filtration to reduce aerosol transmission of COVID-19 in long-term care homes

It’s not just SARS-CoV-2: Most respiratory viruses spread by aerosols.

 

Comentário no Twitter

 

Debate: os comprovantes de vacinação são uma alternativa válida ao lockdown?

5 Nov, 2021 | 17:15h

Are vaccine passports and covid passes a valid alternative to lockdown? – The BMJ

Comunicado de imprensa: Covid passes: the best way of preventing another lockdown or a threat to civil freedoms and rights? – BMJ

Reino Unido aprova a pílula antiviral da Merck para COVID-19.

5 Nov, 2021 | 17:14h

The U.K. approves Merck’s COVID-19 antiviral pill, calling it a world first – NPR

Conteúdos relacionados:

Merck to allow other nations to produce new COVID-19 antiviral.

Video: Merck’s Covid pill could transform treatment. Here’s how it works.

How antiviral pill Molnupiravir shot ahead in the COVID drug hunt.

What we know — and don’t know — about Merck’s new Covid-19 pill.

[Press release – not published yet] Merck announces oral antiviral Molnupiravir reduced the risk of hospitalization or death by approximately 50 Percent compared to placebo for patients with mild or moderate COVID-19.

Merck’s Covid-19 pill is great news but may not be a game-changer.

Video | A Pill For COVID? A Doctor Explains Molnupiravir.

OMS aprova o uso emergencial da vacina indiana Covaxin.

4 Nov, 2021 | 12:09h

WHO issues emergency use listing for eighth COVID-19 vaccine – World Health Organization

Comentários:

WHO Gives India’s Covaxin Approval, Opening the Door to COVAX distribution – Health Policy Watch

WHO green-lights India’s COVID vaccine as global cases rise – CIDRAP

 

Comentário no Twitter (fio – clique para saber mais)

 

Estudo observacional mostrou que a vacina de dose única da J&J teve efetividade de 74% contra Covid-19 sintomática.

4 Nov, 2021 | 12:07h

Analysis of the Effectiveness of the Ad26.COV2.S Adenoviral Vector Vaccine for Preventing COVID-19 – JAMA Network Open

Comentários:

Single-Dose Ad26.COV2.S Vaccine—Room for Improvement – JAMA Network Open

Real-world study shows J&J COVID-19 vaccine 74% effective – CIDRAP

Conteúdos relacionados:

J&J COVID-19 Vaccine: FDA recommends booster shot for all adults aged 18 and older at least two months following initial vaccination with the single-shot vaccine.

[Press release – not published yet] J&J says booster shot at two months provided 75% protection against moderate to severe COVID-19 globally and 94% of such cases in the U.S.

CDC Report: Moderna’s vaccine associated with greater effectiveness (93%) against Covid-19 hospitalization compared to Pfizer (88%) and J&J (71%) vaccines.

[Preprint] Observational study finds single-dose Johnson & Johnson vaccine is 76.7% effective in preventing SARS-CoV-2 infection

RCT: Single-Dose Johnson & Johnson Vaccine has 85% efficacy against severe/critical Covid-19 and maintains efficacy against variant B.1.351

Diretriz do CDC | Pessoas imunocomprometidas podem precisar de uma quarta dose de vacina contra Covid-19.

4 Nov, 2021 | 12:05h

Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the United States – Centers for Disease Control and Prevention

Comentários:

Immunocompromised may need a fourth Covid-19 shot, CDC says – CNN

Some immunocompromised people can receive a 4th Covid shot, CDC says – NBC News

Programa nacional de vacinação contra HPV na Inglaterra foi associado com uma redução estimada de 87% nas taxas de câncer do colo do útero naquelas que receberam a vacina entre 12-13 anos de idade.

4 Nov, 2021 | 11:59h

The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study – The Lancet

Conteúdos relacionados:

Nationwide cohort study in Sweden shows HPV vaccination linked to reduced risk of invasive cervical cancer

CDC: 92% of Human Papillomavirus–Attributable Cancers can be Targeted by HPV Vaccination

Meta-Analysis: Population-level Impact of HPV Vaccination Programs

 

Comentário no Twitter

 

Conselho do CDC endossa a vacina da Pfizer contra Covid-19 para crianças de 5 a 11 anos.

3 Nov, 2021 | 11:18h

Slides da apresentação do ACIP: November 2-3, 2021 Meeting – Centers for Disease Control and Prevention

Comentários:

CDC advisors give go-ahead to COVID-19 vaccines for young kids – CIDRAP

CDC advisers endorse Pfizer’s Covid-19 vaccine for kids 5-11 – STAT

American Academy of Pediatrics Applauds CDC Advisory Committee’s Approval of Safe, Effective COVID-19 Vaccine for Children Ages 5-11

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.